Skip to content

Clinical trials

Completed Phase 1/2 Urinary Bladder Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1/2 Status: Completed Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20053
20063
20082
20092
20101
20112
20122
20133
20141
20153
20161
20183
20195
20201
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center4
Seagen Inc.2
TransThera Sciences (Nanjing), Inc.2
Akamis Bio1
Altor BioScience1
Aprea Therapeutics1
Asieris Pharmaceutical Technologies Co., Ltd.1
Basilea Pharmaceutica1
Cardiff University1
Celldex Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms45
Ovarian Neoplasms12
Prostatic Neoplasms12
Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung9
Stomach Neoplasms9
Esophageal Neoplasms8
Pancreatic Neoplasms7
Uterine Cervical Neoplasms7
Colorectal Neoplasms6

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.